$ASMB
Assembly Biosciences Inc

2015 Q1 Form 10-K Financial Statement

#000114420415015700 Filed on March 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 2013 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.370M $13.24M $12.33M
YoY Change 195.61% -32.45% 1041.67%
% of Gross Profit
Research & Development $3.834M $10.72M -$140.0K
YoY Change 28.95% 134.21% -105.11%
% of Gross Profit
Depreciation & Amortization $13.90K $10.97K $10.00K
YoY Change 998.26% 76.54%
% of Gross Profit
Operating Expenses $3.834M $10.72M $12.19M
YoY Change 28.95% 134.21% 219.11%
Operating Profit -$7.203M -$23.96M
YoY Change 75.25% 22.2%
Interest Expense $60.00K $170.0K $50.00K
YoY Change 50.0% -15.0% 66.67%
% of Operating Profit
Other Income/Expense, Net $58.27K $167.7K
YoY Change 44.82% -16.6%
Pretax Income -$7.140M -$23.79M -$12.14M
YoY Change 75.43% -39.02% 220.32%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.145M -$23.79M -$12.14M
YoY Change 75.56% 22.6% 220.22%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$638.6K -$3.399M -$2.911M
COMMON SHARES
Basic Shares Outstanding 10.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.10M $29.10M $27.10M
YoY Change 307.2% 7.38% 32.2%
Cash & Equivalents $96.05M $29.10M $27.06M
Short-Term Investments
Other Short-Term Assets $283.8K $100.0K $63.67K
YoY Change 9.51% 0.0% 6.86%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $96.34M $29.20M $27.12M
YoY Change 303.16% 7.75% 32.0%
LONG-TERM ASSETS
Property, Plant & Equipment $173.2K $200.0K $7.102K
YoY Change 1956.36% 3.82%
Goodwill $12.74M $0.00
YoY Change
Intangibles $29.00M $0.00
YoY Change
Long-Term Investments $100.0K $100.0K $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $41.96M $42.00M $7.102K
YoY Change 497966.26% 3.82%
TOTAL ASSETS
Total Short-Term Assets $96.34M $29.20M $27.12M
Total Long-Term Assets $41.96M $42.00M $7.102K
Total Assets $138.3M $71.20M $27.13M
YoY Change 478.56% 162.73% 31.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.300M $900.0K $2.615M
YoY Change -9.42% -65.38% 41.54%
Accrued Expenses $877.5K $100.0K $23.44K
YoY Change 3120.45% -97.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.128M $1.100M $2.638M
YoY Change 41.89% -57.69% -2.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.128M $1.100M $2.638M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $13.70M $12.70M $2.638M
YoY Change 836.78% 388.46% -3.91%
SHAREHOLDERS EQUITY
Retained Earnings -$142.7M -$111.7M
YoY Change
Common Stock $4.147K
YoY Change -67.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $124.6M $58.60M $24.49M
YoY Change
Total Liabilities & Shareholders Equity $138.3M $71.20M $27.13M
YoY Change 478.75% 162.73% 31.99%

Cashflow Statement

Concept 2015 Q1 2014 2013 Q4
OPERATING ACTIVITIES
Net Income -$7.145M -$23.79M -$12.14M
YoY Change 75.56% 22.6% 220.22%
Depreciation, Depletion And Amortization $13.90K $10.97K $10.00K
YoY Change 998.26% 76.54%
Cash From Operating Activities -$3.673M -$14.97M -$5.400M
YoY Change -29.16% -15.86% 75.9%
INVESTING ACTIVITIES
Capital Expenditures $30.71K $150.0K $0.00
YoY Change 1086.21% 2215.32%
Acquisitions -$509.4K
YoY Change
Other Investing Activities $430.0K
YoY Change
Cash From Investing Activities -$30.71K $277.4K $0.00
YoY Change 1086.21% -4382.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $70.67M $16.73M 230.0K
YoY Change 3908.1% -31.38%
NET CHANGE
Cash From Operating Activities -$3.673M -$14.97M -5.400M
Cash From Investing Activities -$30.71K $277.4K 0.000
Cash From Financing Activities $70.67M $16.73M 230.0K
Net Change In Cash $66.96M $2.030M -5.170M
YoY Change -2055.38% -69.11% 68.4%
FREE CASH FLOW
Cash From Operating Activities -$3.673M -$14.97M -$5.400M
Capital Expenditures $30.71K $150.0K $0.00
Free Cash Flow -$3.704M -$15.12M -$5.400M
YoY Change -28.6% -15.05% 75.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013 asmb Stock Issued During Period Value Preferred Stock Issued
StockIssuedDuringPeriodValuePreferredStockIssued
5170000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
12654021 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
44 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
4147 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
10672 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
135844320 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
194072572 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29000000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
0 USD
CY2014Q4 us-gaap Goodwill
Goodwill
12737350 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-135512072 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
24493988 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71225193 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111723273 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27132042 USD
CY2013Q4 us-gaap Assets
Assets
27132042 USD
CY2014Q4 us-gaap Assets
Assets
71225193 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2638054 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1054021 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
0 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
11600000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
2638054 USD
CY2013Q4 asmb Common Stock Value Issuable
CommonStockValueIssuable
368750 USD
CY2014Q4 asmb Common Stock Value Issuable
CommonStockValueIssuable
0 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
58571172 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
509363 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
23540 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
10350 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
29000000 USD
CY2014Q3 asmb Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill
12737350 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
42297209 USD
CY2014Q3 asmb Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses
874113 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
11600000 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
12474113 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
29823096 USD
CY2014Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
4008848 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4146779 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10672059 shares
CY2013Q4 asmb Common Stock Issuable Shares
CommonStockIssuableShares
125000 shares
CY2014Q4 asmb Common Stock Issuable Shares
CommonStockIssuableShares
0 shares
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 USD
CY2014 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
29000000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29000000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
467698 shares
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Options Assumed
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumed
621651 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2750700 shares
CY2014 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
590398 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1086425 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.35
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Options Assumed Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedWeightedAverageExercisePrice
2.22
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.75
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
621651 shares
CY2014Q3 asmb Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock
NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock
758948 USD
CY2014Q3 asmb Noncash Or Part Noncash Acquisition Share Exchange Business Combination
NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination
29064148 USD
CY2014 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
12737350 USD
CY2014 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
29823096 USD
CY2014Q4 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
0 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4146779 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10672059 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
26.84
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.26
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.17
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Options Assumed Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedAggregateIntrinsicValue
3506112 USD
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue
1689600 USD
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalIntrinsicValue
0 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5187924 USD
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1832125 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2014Q4 asmb Future Stock Based Compensation Expense Remainder Of Fiscal Year
FutureStockBasedCompensationExpenseRemainderOfFiscalYear
6280264 USD
CY2014Q4 asmb Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
1703957 USD
CY2014Q4 asmb Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
34943 USD
CY2014Q4 asmb Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
8019164 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
172209 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
120265 shares
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod
21713 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
270761 shares
CY2014Q4 asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Instrumen Ts Other Than Options Exercisable In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumenTsOtherThanOptionsExercisableInPeriod
270761 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
38.85
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.13
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13239715 USD
CY2013 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
19604779 USD
CY2014 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
23956452 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-19604779 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-23956452 USD
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue
33.00
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.34
CY2014Q4 asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
24.34
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
75000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
75000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
0 shares
CY2013Q4 asmb Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
10.20
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Non Option Forfeited Weighted Average Grant Date Fairvalue
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityNonOptionForfeitedWeightedAverageGrantDateFairvalue
10.20
CY2014Q4 asmb Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
0
CY2014Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14963000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15003740 USD
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1959000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
514445 shares
CY2014Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2560000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.20
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y6M
CY2014Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
The Company’s Board of Directors and stockholders approved a 1-for-5 reverse stock split of the Company’s common stock. The reverse stock split became effective on July 11, 2014. All share and per share amounts in the consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
57953 shares
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
679447 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4575701 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10716737 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15029078 USD
CY2013 us-gaap Interest Income Other
InterestIncomeOther
201020 USD
CY2014 us-gaap Interest Income Other
InterestIncomeOther
167653 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
201020 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
167653 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-19403759 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-23788799 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.00
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.40
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3878697 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6998875 shares
CY2013 us-gaap Depreciation
Depreciation
6216 USD
CY2014 us-gaap Depreciation
Depreciation
10974 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1712947 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2013 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4088 USD
CY2014 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
54472 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17796088 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14973502 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6477 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
149963 USD
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-509363 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6477 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
277401 USD
CY2013 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
24374614 USD
CY2014 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
16725946 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24374614 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16725946 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6572049 USD
CY2014 asmb Noncash Or Part Noncash Acquisition Other Current Goodwill
NoncashOrPartNoncashAcquisitionOtherCurrentGoodwill
12737350 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2029845 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20489219 USD
CY2013 asmb Noncash Or Part Noncash Acquisition Other Current Assets
NoncashOrPartNoncashAcquisitionOtherCurrentAssets
0 USD
CY2014 asmb Noncash Or Part Noncash Acquisition Other Current Assets
NoncashOrPartNoncashAcquisitionOtherCurrentAssets
23540 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
10350 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
29000000 USD
CY2013 asmb Noncash Or Part Noncash Acquisition Other Current Goodwill
NoncashOrPartNoncashAcquisitionOtherCurrentGoodwill
0 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
874113 USD
CY2013 asmb Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock
NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock
0 USD
CY2014 asmb Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock
NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock
758948 USD
CY2013 asmb Noncash Or Part Noncash Acquisition Deferred Tax Liability
NoncashOrPartNoncashAcquisitionDeferredTaxLiability
0 USD
CY2014 asmb Noncash Or Part Noncash Acquisition Deferred Tax Liability
NoncashOrPartNoncashAcquisitionDeferredTaxLiability
11600000 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
-509363 USD
CY2013 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2014 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
440 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
17810186 USD
CY2014 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
29064148 USD
CY2014 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
758948 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
679447 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1344197 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10637494 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
ASSEMBLY BIOSCIENCES, INC.
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001426800
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q2 dei Entity Public Float
EntityPublicFloat
30500000 USD
CY2014 dei Trading Symbol
TradingSymbol
ASMB
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10695259 shares
CY2014 asmb Percentage Of Restricted Stock Units Vested Descriptions
PercentageOfRestrictedStockUnitsVestedDescriptions
The Company valued the restricted stock grant, 75% of which vests in three equal installments when the 20-day trading volume weighted average price of the Company’s common stock is at least $20.75, $25.75 and $30.75, using the Monte Carlo simulation model.
CY2014Q3 us-gaap Security Deposit
SecurityDeposit
16606 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Use of estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Significant estimates inherent in the preparation of the accompanying financial statements include recoverability and useful lives of long-lived assets, the valuation allowance related to the Company&#8217;s deferred tax assets and the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain of the Company&#8217;s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company&#8217;s estimates and could cause actual results to differ from those estimates and assumptions.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Concentrations of Credit Risk</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.2in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments which potentially subject the Company to credit risk consist primarily of cash, cash equivalents and marketable securities. The Company holds these investments in highly rated financial institutions, and, by policy, limits the amounts of credit exposure to any one financial institution. These amounts at times may exceed federally insured limits. The Company has not experienced any credit losses in such accounts and does not believe it is exposed to any significant credit risk on these funds. The Company has no off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38094000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
11800 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.20
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
32193000 USD
CY2014 asmb Share Based Compensation Arrangement By Share Based Payment Award Options Expiration In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationInPeriodTotalIntrinsicValue
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6617000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11691000 USD
CY2013Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
6017000 USD
CY2014Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
5697000 USD
CY2013Q4 asmb Deferred Tax Assets Related Party Interest
DeferredTaxAssetsRelatedPartyInterest
2149000 USD
CY2014Q4 asmb Deferred Tax Assets Related Party Interest
DeferredTaxAssetsRelatedPartyInterest
2600000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46976000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
58084000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46976000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
58084000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.110 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.110 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.450 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.450 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
79958236 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2600174 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
86551323 USD
CY2013Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
2614619 USD
CY2014Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
907601 USD
CY2013Q4 us-gaap Security Deposit
SecurityDeposit
0 USD
CY2014Q4 us-gaap Security Deposit
SecurityDeposit
115005 USD
CY2013 asmb Stock Issued During Period Value Common Stock Issued
StockIssuedDuringPeriodValueCommonStockIssued
19204614 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
767374 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2481917 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-874778 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
23771 USD
CY2014 asmb Stock Issued During Period Value Common Stock Issued
StockIssuedDuringPeriodValueCommonStockIssued
16725946 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23435 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
146420 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
13,000 of these options vest one third on the date of grant, one third on the first anniversary of the option grant date and one third on the second anniversary of the option grant date. The other 55,000 options vest one third on the first anniversary of the option grant date, one third on the second anniversary of the option grant date and one third on the third anniversary of the option grant date.
CY2013 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 USD
CY2014 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-81999 USD
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
758907 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3520412 shares
CY2013 asmb Noncash Or Part Non Cash Security Deposit
NoncashOrPartNonCashSecurityDeposit
0 USD
CY2014 asmb Noncash Or Part Non Cash Security Deposit
NoncashOrPartNonCashSecurityDeposit
16606 USD
CY2013 asmb Noncash Or Part Noncash Acquisition Share Exchange Business Combination
NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination
0 USD
CY2014 asmb Noncash Or Part Noncash Acquisition Share Exchange Business Combination
NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination
29064148 USD
CY2014Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
8.04
CY2014Q4 asmb Percentage Of Placement Agent Fee
PercentageOfPlacementAgentFee
0.050 pure
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
8400 USD
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
11800 shares
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 USD
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
11600000 USD
CY2013 asmb Share Based Compensation Arrangement By Share Based Payment Award Restricted Value Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedValueGrantedInPeriod
368750 USD
CY2014 asmb Stock Issued During Period Value In Exchange For Restricted Stock Units
StockIssuedDuringPeriodValueInExchangeForRestrictedStockUnits
0 USD
CY2013 us-gaap Stock Issued1
StockIssued1
0 USD
CY2014 us-gaap Stock Issued1
StockIssued1
368750 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
0 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
11600000 USD
CY2013 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
0 USD
CY2014 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
0 USD
CY2013 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-20347860 USD
CY2014 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-26352751 USD
CY2013 asmb Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-2.58
CY2014 asmb Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-2.90

Files In Submission

Name View Source Status
0001144204-15-015700-index-headers.html Edgar Link pending
0001144204-15-015700-index.html Edgar Link pending
0001144204-15-015700.txt Edgar Link pending
0001144204-15-015700-xbrl.zip Edgar Link pending
asmb-20141231.xml Edgar Link completed
asmb-20141231.xsd Edgar Link pending
asmb-20141231_cal.xml Edgar Link unprocessable
asmb-20141231_def.xml Edgar Link unprocessable
asmb-20141231_lab.xml Edgar Link unprocessable
asmb-20141231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v403581_10k.htm Edgar Link pending
v403581_ex21-1.htm Edgar Link pending
v403581_ex23-1.htm Edgar Link pending
v403581_ex31-1.htm Edgar Link pending
v403581_ex31-2.htm Edgar Link pending
v403581_ex32-1.htm Edgar Link pending
v403581_ex32-2.htm Edgar Link pending